Skip to main content

Table 5 Factors associated with anticoagulant therapy in all patients and those with high risk of stroke (Multivariate logistic regression)

From: Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study

 All patientsPatients with high risk of stroke
VariablesBOR (95% CI)P valueBOR (95% CI)P value
Gender, Female0.1851.203 (0.820~1.763)0.3450.0911.096 (0.641~1.874)0.739
Payment, Self-paying0.5551.742 (1.086~2.794)0.0210.8352.305 (1.186~4.478)0.014
Age (per 1 year increase)0.0241.024 (0.997~1.053)0.0850.0841.087 (1.041~1.135)< 0.001
Education−0.1080.897 (0.590~1.364)0.612−0.0690.934 (0.555~1.572)0.796
AF type, Permanent−0.8570.424 (0.215~0.839)0.014−0.5520.576 (0.264~1.255)0.165
Duration, ≥5 years0.3861.471 (1.006~2.149)0.0460.2861.332 (0.858~2.067)0.202
Severity of symptom0.1321.141 (0.715~1.819)0.5800.0431.044 (0.586~1.860)0.884
HAS-BLED, score ≥ 3−0.3390.712 (0.369~1.375)0.312−0.2890.749 (0.364~1.540)0.432
CHA2DS2-VASC,(per1score increase)−0.1080.897 (0.713~1.130)0.3570.0151.015 (0.750~1.374)0.923
Hypertension   0.4651.592 (0.933~2.717)0.088
  1. Adjustment variable: congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke, transient ischemic attack, orth romboembolism, vascular disease, sex category (female)
  2. Abbreviations: AF atrial fibrillation, CHA2DS2-VASc Congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke, transient ischemic attack, or thromboembolism, vascular disease, age 65–74 years, sex category (female), CI Confidence interval, HAS-BLED Hypertension, abnormal renal and/or liver function, stroke, bleeding history or predisposition, labile international normalized ratio, elderly (age > 65 years), drugs and/or alcohol concomitantly, OR Odds ratio